甲状腺玻璃样变梁状肿瘤:GLIS3免疫组化检测PAX8::GLIS3重排的价值
该回顾性研究对8例组织学诊断为甲状腺玻璃样变梁状肿瘤(HTT)的病例进行RNA测序和GLIS3免疫组化染色。RNA测序显示6例(86%)存在PAX8::GLIS3重排,所有检出基因融合的病例肿瘤细胞GLIS3核阳性表达(100%),20例HTT模仿者均无GLIS3免疫染色。研究表明GLIS3免疫组化可提高HTT诊断准确性。
要点
- HTT中PAX8::GLIS3重排发生率高,RNA测序6/8例(86%)检出。
- GLIS3免疫组化核阳性与PAX8::GLIS3融合检测一致(100%)。
- 20例HTT模仿者无GLIS3免疫染色,有助于鉴别诊断。
核心结论
- 甲状腺玻璃样变梁状肿瘤(HTT)中PAX8::GLIS3重排持续存在。
- GLIS3免疫组化核阳性表达与RNA测序检测PAX8::GLIS3融合相关,可提高诊断精确性并可能加速HTT诊断。
研究设计与样本
- 回顾性研究纳入8例组织学诊断为HTT的病例。
- 对所有病例进行RNA测序和GLIS3免疫组化染色。
- 对照组为20例HTT模仿者。
主要发现
- 8例中5例女性、3例男性,肿瘤大小3至45 mm。
- RNA测序显示6例(86%)存在PAX8::GLIS3重排,未发现其他分子改变。
- 1例因组织质量测序失败,1例未显示任何基因融合。
- 所有检出基因融合的病例肿瘤细胞GLIS3核阳性表达(100%)。
- 20例HTT模仿者均无GLIS3免疫染色。
关键数值与推荐
- RNA测序检出PAX8::GLIS3重排6/8例(86%)。
- GLIS3免疫组化核阳性在融合阳性病例中为100%(6/6)。
- 对照组20例HTT模仿者GLIS3免疫染色阴性。
临床怎么用
- 对组织学怀疑HTT的病例可行GLIS3免疫组化辅助诊断。
- GLIS3核阳性表达支持PAX8::GLIS3融合存在,有助于与HTT模仿者鉴别。
局限性
- 样本量小(8例HTT)。
- 1例因组织质量RNA测序失败,1例未检出基因融合。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: & Objective: Hyalinizing trabecular tumor of the thyroid (HTT) is a rare, low-risk neoplasm that poses diagnostic challenges. Very recently, PAX8::GLIS3 rearrangements were found to characterize HTT. We aimed to explore HTT's genetic profile, focusing on PAX8::GLIS3 rearrangements and GLIS3 immunohistochemical staining. METHODS: We conducted a retrospective study involving 8 cases histologically diagnosed as HTT. RNA sequencing and immunohistochemical staining for GLIS3 were performed on all cases. RESULTS: The study included five females and three males, with a tumor size ranging from 3 to 45 mm. RNA sequencing analysis showed PAX8::GLIS3 rearrangement in 6 cases (86 %). No other molecular alterations were found. However, one case failed due to the tissue quality, and one case did not show any gene fusion. Immunohistochemical staining for GLIS3 revealed nuclear positive expression in tumor cells for all cases where gene fusion was detected (100 %). A control group of 20 HTT mimickers showed no immunostaining for GLIS 3. CONCLUSION: Our study confirms the consistent presence of PAX8::GLIS3 rearrangement in hyalinizing trabecular tumor (HTT) of the thyroid. Additionally, our novel finding of GLIS3 expression via immunohistochemistry enhances diagnostic precision for these tumors. Notably, our series demonstrates the correlation between positive GLIS3 expression and detection of PAX8::GLIS3 fusion by RNA sequencing, potentially expediting HTT diagnosis.
引用
- Alsugair Z, Descotes F, Lopez J, et al. Hyalinizing trabecular tumor of the thyroid: Interest of GLIS3 immunohistochemical study to detect PAX8::GLIS3 rearrangement. Hum Pathol. 2025. PMID: 40122401. doi:10.1016/j.humpath.2025.105761
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。